Broadlake Capital

Broadlake Capital is a Dublin-based private investment company that backs established, founder-led Irish businesses, with healthcare exposure concentrated in tech-enabled care delivery and consumer wellness. Unlike a traditional buyout shop, Broadlake positions itself as a long-term partner to owner-operators who want growth capital without surrendering operational control. The firm is sector-agnostic in mandate, and its healthcare activity reflects opportunistic backing of category leaders rather than a dedicated vertical thesis. Broadlake does not market an AI focus, and limited public information is available about its named investment team beyond the firm’s general partner profile.

The firm operates at the growth stage, writing equity checks in the $5M to $25M range that suit profitable mid-market companies looking to professionalize, expand geographically, or pursue add-on acquisitions. Geographic focus centers on the Republic of Ireland with selective activity into the United Kingdom, and Broadlake typically targets businesses that have already crossed early commercial validation and now need patient capital to support a multi-year growth plan.

For founders, the Broadlake approach is built around partnership with operating teams rather than wholesale management replacement. The firm tends to favor businesses with durable cash flows, defensible service models, and management teams comfortable with active governance and strategic input. Founders should expect detailed diligence on unit economics and a longer-than-average hold horizon, with limited interest in pre-profit venture profiles. Health and wellness operators that fit the Irish mid-market profile and want a hands-on growth partner rather than a transactional financial sponsor are the natural audience for Broadlake.